Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease

Neurobiology of Disease

Volumn 65, Issue , 2014, Pages 188-192

  Morabito, Michael V ^a   Berman, Diego E ^a   Schneider, Remy T ^a   Zhang, Yiying ^a   Leibel, Rudolph L ^a   Small, Scott A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Alzheimer's disease; Diabetes; Obesity; Retromer

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; LEPTIN RECEPTOR; LEUCINE; MEMBRANE PROTEIN; PROTEIN VPS26; PROTEIN VPS35; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID DEFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BRAIN CELL CULTURE; BRAIN DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HIPPOCAMPAL RETROMER DEFICIENCY; HUMAN; HYPERLEUCINEMIA; INSULIN RESISTANCE; MALE; MORBID OBESITY; MOUSE; NERVE CELL GROWTH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALZHEIMER'S DISEASE; DIABETES; OBESITY; RETROMER;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMALS; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE TOLERANCE TEST; HIPPOCAMPUS; HUMANS; LEPTIN; LEUCINE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROBLASTOMA; VESICULAR TRANSPORT PROTEINS;

EID: 84896726471     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.12.017     Document Type: Article

References (38)

1. Adams S.H. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv. Nutr. 2011, 2:445-456.
2. Araujo P., et al. Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem. Int. 2001, 38:529-537.
3. Bhalla A., et al. The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport. Neurobiol. Dis. 2012, 47:126-134.
4. Bonifacino J.S., Hurley J.H. Retromer. Curr. Opin. Cell Biol. 2008, 20:427-436.
5. Burda P., et al. Retromer function in endosome-to-Golgi retrograde transport is regulated by the yeast Vps34 PtdIns 3-kinase. J. Cell Sci. 2002, 115:3889-3900.
6. Combs T.P., et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004, 145:367-383.
7. Gandy S., DeKosky S.T. Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. Annu. Rev. Med. 2013, 64:367-383.
8. Greco S.J., et al. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J. Alzheimers Dis. 2010, 19:1155-1167.
9. Holden K.F., et al. Serum leptin level and cognition in the elderly: findings from the Health ABC Study. Neurobiol. Aging 2009, 30:1483-1489.
10. Killian D.M., Chikhale P.J. Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature. Neurosci. Lett. 2001, 306:1-4.
11. Kim J.Y., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 2007, 117:2621-2637.
12. Kruse T., et al. Amino acid transport across the human blood-CSF barrier. An evaluation graph for amino acid concentrations in cerebrospinal fluid. J. Neurol. Sci. 1985, 70:129-138.
13. Lane R.F., et al. Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes. J. Neurosci. 2012, 32:14080-14086.
14. Li J., et al. Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice. Pharmacol. Biochem. Behav. 2012, 101:564-574.
15. Lieb W., et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009, 302:2565-2572.
16. Luchsinger J.A. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. Eur. J. Pharmacol. 2008, 585:119-129.
17. Luchsinger J.A., et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 2001, 154:635-641.
18. Marwarha G., et al. Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. J. Alzheimers Dis. 2010, 19:1007-1019.
19. Melnik B.C. Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J. Diabetes 2012, 3:38-53.
20. Morel E., et al. Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system. Nat. Commun. 2013, 4:2250.
21. Muhammad A., et al. Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7327-7332.
22. Newgard C.B. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012, 15:606-614.
23. Rafecas I., et al. Plasma amino acids of lean and obese Zucker rats subjected to a cafeteria diet after weaning. Biochem. Int. 1991, 25:797-806.
24. Ridaura V.K., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013, 341:1241214.
25. Rogaeva E., et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 2007, 39:168-177.
26. She P., et al. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1552-E1563.
27. Siegenthaler B.M., Rajendran L. Retromers in Alzheimer's disease. Neurodegener. Dis. 2012, 10:116-121.
28. Small S.A., et al. Model-guided microarray implicates the retromer complex in Alzheimer's disease. Ann. Neurol. 2005, 58:909-919.
29. Son S.M., et al. Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway. Diabetes 2012, 61:3126-3138.
30. Sullivan C.P., et al. Retromer disruption promotes amyloidogenic APP processing. Neurobiol. Dis. 2011, 43:338-345.
31. Takeda S., et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7036-7041.
32. Tosto G., Reitz C. Genome-wide association studies in Alzheimer's disease: a review. Curr. Neurol. Neurosci. Rep. 2013, 13:381.
33. Vardarajan B.N., et al. Identification of Alzheimer disease-associated variants in genes that regulate retromer function. Neurobiol. Aging 2012, 33:2231.e15-2231.e30.
34. Vieira S.I., et al. Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated. Mol. Neurodegener. 2010, 5:40.
35. Wang T.J., et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 2011, 17:448-453.
36. Wen L., et al. VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J. Cell Biol. 2011, 195:765-779.
37. Wijekoon E.P., et al. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can. J. Physiol. Pharmacol. 2004, 82:506-514.
38. Yamauchi T., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 2003, 278:2461-2468.